Alvin L.

Alvin L. has a diverse and extensive work experience in the pharmaceutical and biotechnology industry, with a focus on commercial strategy and marketing. Alvin has held high-level positions in various companies, including Vera Therapeutics, Zai Lab, Portola Pharmaceuticals, Pharmacyclics (an AbbVie Company), Alexion Pharmaceuticals, and Merck.

At Vera Therapeutics, Alvin served as the Vice President of Commercial Strategy, where they were responsible for developing strategies and plans for the potential launch of three rare-disease product candidates. Alvin oversaw various aspects of commercial planning, including product profiles, competitive intelligence, forecasts, marketing, market access, market research, sales planning, and patient advocacy.

Before joining Vera Therapeutics, Alvin worked at Zai Lab as the Executive Director of Lifecycle Leader and Head of Global Strategic Marketing. In this role, they focused on lifecycle management, new product planning, and commercial assessment for a diverse clinical portfolio of product candidates.

Prior to their time at Zai Lab, Alvin held multiple roles at Portola Pharmaceuticals, where they served as the Executive Director of Lifecycle Management and Head of Global Strategic Marketing. Alvin was responsible for overseeing new indications and trials in the pipeline, as well as leading new product planning efforts. Alvin also served as the Senior Director of EU & Global Marketing at Portola Pharmaceuticals.

Alvin's earlier experiences include their role as the Director of US Marketing for IMBRUVICA at Pharmacyclics, where they led the hematology team and oversaw all aspects of US marketing. Alvin also worked at Alexion Pharmaceuticals as the US Marketing Lead for PNH and as a Senior Manager in US Marketing SOLIRIS.

Before entering the pharmaceutical industry, Alvin gained experience in venture capital as the Principal Fund Manager at Big Red Ventures. Alvin also worked in technology licensing at the Massachusetts Institute of Technology and Harvard Medical School.

Alvin's work experience demonstrates their expertise in commercial strategy, marketing, and lifecycle management within the pharmaceutical and biotechnology sectors.

Alvin L. has a strong background in education, with a focus on molecular biology, business administration, and graduate studies in medicine. Alvin attended the Massachusetts Institute of Technology, where they studied molecular biology, though the specific years are not provided. Later, they pursued an MBA from Cornell Johnson Graduate School of Management, again without specific years mentioned. Lastly, Alvin L. attended Tufts University School of Medicine for graduate studies, though the degree name is not mentioned.